FDA approves Wellstat's Vistogard for chemotherapy overdose
The US Food and Drug Administration (FDA) has approved Wellstat Therapeutics' Vistogard (uridine triacetate) to treat overdose of fluorouracil or capecitabine, which are administered for several malignancies.
Click on this link for more information.
